Related Experiment Video
Updated: Oct 9, 2026
Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping
V Sirivatanauksorn1, Y Sirivatanauksorn, P A Gorman
1Imperial Cancer Research Fund Molecular Oncology Unit, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom.
Abstract:
The molecular events involved in pancreatic cancer are becoming increasingly well characterized, with mutations in the dominant oncogene KRAS and the tumour suppressor genes TP53, CDKN2A and MADH4 being typically observed. However, other genetic abnormalities remain to be identified and molecular cytogenetics may be useful to detect chromosomal loci involved in recurrent rearrangements. We have used spectral karyotyping to characterize cytogenetic aberrations in a panel of 20 human pancreatic carcinoma cell lines and confirmed their identities by dual and triple color fluorescence in situ hybridization. The most common partial or whole-arm gains involved 5p, 7q, 12p, 1q, 7p, 5q, 9p, 9q and 11p. The most common partial or whole-arm losses affected 9p, 11q, 18q, 3p, 2q and 1p, as well as the short arms of the acrocentric chromosomes. Spectral karyotyping allowed us to identify a number of recurrent structural aberrations, all of them unbalanced: most frequently i(5)(p10), del(11)(q23), i(12)(p10), i(1)(q10), del(7)(q22) and del(10)(p11). Spectral karyotyping mapped the complex aberrations occurring in pancreatic cancer cell lines and identified non-random patterns of chromosomal rearrangement. This comprehensive characterization should be useful to direct future investigation. The observation that loss at 11q and gains at 5p with i(5)(p10) and 12p with i(12)(p10) are more frequent changes than previously reported would justify more intensive investigation of these chromosomal regions.
Insights
This study used spectral karyotyping to identify chromosomal abnormalities in pancreatic cancer cell lines. Key findings include recurrent gains at 5p and 12p, and losses at 11q, suggesting new targets for pancreatic cancer research.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Pancreatic cancer molecular landscape is partly understood, with known mutations in KRAS, TP53, CDKN2A, and MADH4.
- Identifying additional genetic abnormalities is crucial for understanding pancreatic cancer development.
- Molecular cytogenetics offers a method to detect chromosomal rearrangements.
Purpose of the Study:
- To characterize cytogenetic aberrations in human pancreatic carcinoma cell lines.
- To identify recurrent chromosomal rearrangements in pancreatic cancer.
- To provide a comprehensive map of chromosomal alterations for future research.
Main Methods:
- Spectral karyotyping was employed on 20 human pancreatic carcinoma cell lines.
- Dual and triple color fluorescence in situ hybridization confirmed identified aberrations.
- Analysis focused on identifying partial or whole-arm gains and losses, and structural aberrations.
Main Results:
- Common partial or whole-arm gains were observed at 5p, 7q, 12p, 1q, 7p, 5q, 9p, 9q, and 11p.
- Frequent partial or whole-arm losses affected 9p, 11q, 18q, 3p, 2q, 1p, and acrocentric chromosome short arms.
- Recurrent unbalanced structural aberrations included i(5)(p10), del(11)(q23), i(12)(p10), i(1)(q10), del(7)(q22), and del(10)(p11).
Conclusions:
- Spectral karyotyping revealed non-random patterns of chromosomal rearrangement in pancreatic cancer.
- Loss at 11q and gains at 5p (i(5)(p10)) and 12p (i(12)(p10)) are more frequent than previously reported.
- These findings warrant further investigation into specific chromosomal regions for potential therapeutic targets.
